Civic Intelligence

Breast Cancer Think Tank Inc

EIN 45-3942883 • 501(c)3 • Hollywood, FL

Profile

Breast cancer think tank, inc. Is a non-profit organization established to promote research and education relating to breast cancer research, through lectures.

4429 Hollywood Blvd No 814833Hollywood, FL 33021
Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

31st percentile

-9.9%

Higher net margin than 31% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

38th percentile

-12%

Faster asset growth than 38% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

35th percentile

-18%

Faster revenue growth than 35% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Assets

Down

$254,220

Down $34,041 (-12%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Down

$254,220

Down $34,041 (-12%) from 2023

Revenue

Down

$342,250

Down $77,250 (-18%) from 2023

Expenses

Up

$376,291

Up $111,904 (+42%) from 2023

Net Income

Down

-$34,041

Down $189,154 (-122%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2011: $28,498Liabilities 2011: $02011Assets 2012: $33,421Liabilities 2012: $02012Assets 2013: $39,035Liabilities 2013: $02013Assets 2014: $30,580Liabilities 2014: $02014Assets 2015: $48,980Liabilities 2015: $02015Assets 2016: $65,364Liabilities 2016: $0Net Assets 2016: $65,3642016Assets 2017: $93,919Liabilities 2017: $0Net Assets 2017: $93,9192017Assets 2018: $30,962Liabilities 2018: $0Net Assets 2018: $30,9622018Assets 2019: $98,325Liabilities 2019: $0Net Assets 2019: $98,3252019Assets 2020: $30,962Liabilities 2020: $02020Assets 2021: $27,624Liabilities 2021: $02021Assets 2023: $288,261Liabilities 2023: $0Net Assets 2023: $288,2612023Assets 2024: $254,220Liabilities 2024: $0Net Assets 2024: $254,2202024

Highlighted filing

2024

Assets$254,220
Liabilities$0
Net Assets$254,220

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$600K$400K$200K$0-$200KRevenue 2011: $98,100Expenses 2011: $69,601Net Income 2011: $28,4992011Revenue 2012: $150,797Expenses 2012: $145,873Net Income 2012: $4,9242012Revenue 2013: $124,500Expenses 2013: $118,886Net Income 2013: $5,6142013Revenue 2014: $171,841Expenses 2014: $180,295Net Income 2014: -$8,4542014Revenue 2015: $248,979Expenses 2015: $230,580Net Income 2015: $18,3992015Revenue 2016: $232,653Expenses 2016: $216,269Net Income 2016: $16,3842016Revenue 2017: $158,467Expenses 2017: $159,860Net Income 2017: -$1,3932017Revenue 2018: $237,426Expenses 2018: $300,383Net Income 2018: -$62,9572018Revenue 2019: $305,557Expenses 2019: $231,764Net Income 2019: $73,7932019Revenue 2020: $109,554Expenses 2020: $176,918Net Income 2020: -$67,3642020Revenue 2021: $73,052Expenses 2021: $76,390Net Income 2021: -$3,3382021Revenue 2023: $419,500Expenses 2023: $264,387Net Income 2023: $155,1132023Revenue 2024: $342,250Expenses 2024: $376,291Net Income 2024: -$34,0412024

Highlighted filing

2024

Revenue$342,250
Expenses$376,291
Net Income-$34,041

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Jul 24, 2025
Return Version
2024v5.0
Gross Receipts
$342,250
Mission and Program Overview

Mission

Annually this organization hosts the breast cancer think tank symposium. The breast cancer think tank symposium discusses the newest information and clinical management of breast cancer in order to identify new strategies for diagnosis, prognosis, treatment and prevention of breast cancer in the decades to come. We strive to provide state-of-the-art information to enhance the quality of education, research, and clinical practice, to foster professional growth and to stimulate academic dialogue.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$288,261$254,220▼ $34,041
Total Assets$288,261$254,220▼ $34,041
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$288,261$254,220▼ $34,041
Total Net Assets Fund Balance$288,261$254,220▼ $34,041
Total Liabilities and Net Assets / Fund Balance$288,261$254,220▼ $34,041
Compensation and Service Providers

Board Members and Trustees

NameTitle
Dr Marc LippmanPresident
Ben ParkBoard Member
C Kent OsborneBoard Member
Mothaffar RimawiBoard Member
Merlyn DonatienSecretary
Dr Steffi OesterreichTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$342,250
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$342,250
Change in Net Assets
$-34,041
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$376,291
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Travel$24,387--$24,387
Fees for Services Accounting-$1,597-$1,597
Office Expenses-$1,346-$1,346
Occupancy-$842-$842
Other Expenses$262--$262
Total Functional Expenses$372,506$3,785$0$376,291
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

The board reviews the form 990 before filing with the irs.

Form 990, Page 6, Part VI, Line 12C

The board of directors conducts an annual review of the policy, and the president formally approves and signs all related records.

Form 990, Page 6, Part VI, Line 19

The organization's governing documents, conflict of interest policy, and financial statements are available to the public upon request to the organization.

Filing and Contact Details

Filer

Filer Name
Breast Cancer Think Tank Inc
EIN
45-3942883
Phone
3052437265
Address
4429 HOLLYWOOD BLVD NO 814833, HOLLYWOOD, FL 33021

Signing Officer

Name
Dr Marc Lippman
Title
President
Phone
3052437265
Signed
2025-07-24

Organization Details

Principal Officer
Dr Marc Lippman
Formed
2011
Legal Domicile
Fl
Voting Board Members
3
Independent Board Members
3
Employees
0

Preparer

Firm
Brytebridge Consulting LLC
Address
7021 UNIVERSITY BLVD, WINTER PARK, FL 32792-6719
Preparer
Maria Tapia
Phone
8778579002
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Annually this organization hosts the breast cancer think tank symposium. The breast cancer think tank symposium discusses the newest information and clinical management of breast cancer in order to identify new strategies for diagnosis, prognosis, treatment and prevention of breast cancer in the decades to come. We strive to provide state-of-the-art information to enhance the quality of education, research, and clinical practice, to foster professional growth and to stimulate academic dialogue.

Form 990, Page 2, Part III, Line 4A

The breast cancer think tank symposium is an essential meeting that will contribute significantly to the advancement of breast cancer research and clinical care. By facilitating cross-disciplinary collaboration and sharing the latest knowledge, this symposium aims to foster the development of new diagnostic tools, treatments, and preventive strategies that will shape the future of breast cancer care for decades to come. Our top achievements also include the following: o engagement: active participation from a broad spectrum of professionals, including clinical and basic researchers, industry representatives, and healthcare providers. O innovative insights: generation of new ideas for diagnostics, therapies, and prevention strategies for breast cancer. O collaboration and partnerships: establishment of new collaborations among researchers, clinicians, and companies that can drive forward new research and clinical applications. O impact on future research and clinical practice: concrete steps taken toward overcoming barriers in breast cancer care, translating research findings into actionable solutions for the future.

Raw XML Appendix291 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0ANNUALLY THIS ORGANIZATION HOSTS THE BREAST CANCER THINK TANK SYMPOSIUM. THE BREAST CANCER THINK TANK SYMPOSIUM DISCUSSES THE NEWEST INFORMATION AND CLINICAL MANAGEMENT OF BREAST CANCER IN ORDER TO IDENTIFY NEW STRATEGIES FOR DIAGNOSIS, PROGNOSIS, TREATMENT AND PREVENTION OF BREAST CANCER IN THE DECADES TO COME. WE STRIVE TO PROVIDE STATE-OF-THE-ART INFORMATION TO ENHANCE THE QUALITY OF EDUCATION, RESEARCH, AND CLINICAL PRACTICE, TO FOSTER PROFESSIONAL GROWTH AND TO STIMULATE ACADEMIC DIALOGUE.
IRS990/AllOtherContributionsAmt0342250
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BooksInCareOfDetail/PersonNm0DR MARC LIPPMAN
IRS990/BooksInCareOfDetail/PhoneNum03052437265
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt04429 HOLLYWOOD BLVD
IRS990/BooksInCareOfDetail/USAddress/AddressLine2Txt0NO 814833
IRS990/BooksInCareOfDetail/USAddress/CityNm0HOLLYWOOD
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0FL
IRS990/BooksInCareOfDetail/USAddress/ZIPCd033021
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0288261
IRS990/CashNonInterestBearingGrp/EOYAmt0254220
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0342250
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0376291
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-34041
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0376291
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0342250
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0THE BREAST CANCER THINK TANK SYMPOSIUM IS AN ESSENTIAL MEETING THAT WILL CONTRIBUTE SIGNIFICANTLY TO THE ADVANCEMENT OF BREAST CANCER RESEARCH AND CLINICAL CARE. BY FACILITATING CROSS-DISCIPLINARY COLLABORATION AND SHARING THE LATEST KNOWLEDGE, THIS SYMPOSIUM AIMS TO FOSTER THE DEVELOPMENT OF NEW DIAGNOSTIC TOOLS, TREATMENTS, AND PREVENTIVE STRATEGIES THAT WILL SHAPE THE FUTURE OF BREAST CANCER CARE FOR DECADES TO COME. OUR TOP ACHIEVEMENTS ALSO INCLUDE THE FOLLOWING: O ENGAGEMENT: ACTIVE PARTICIPATION FROM A BROAD SPECTRUM OF PROFESSIONALS, INCLUDING CLINICAL AND BASIC RESEARCHERS, INDUSTRY REPRESENTATIVES, AND HEALTHCARE PROVIDERS. O INNOVATIVE INSIGHTS: GENERATION OF NEW IDEAS FOR DIAGNOSTICS, THERAPIES, AND PREVENTION STRATEGIES FOR BREAST CANCER. O COLLABORATION AND PARTNERSHIPS: ESTABLISHMENT OF NEW COLLABORATIONS AMONG RESEARCHERS, CLINICIANS, AND COMPANIES THAT CAN DRIVE FORWARD NEW RESEARCH AND CLINICAL APPLICATIONS. O IMPACT ON FUTURE RESEARCH AND CLINICAL PRACTICE: CONCRETE STEPS TAKEN TOWARD OVERCOMING BARRIERS IN BREAST CANCER CARE, TRANSLATING RESEARCH FINDINGS INTO ACTIONABLE SOLUTIONS FOR THE FUTURE.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0372506
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt01597
IRS990/FeesForServicesAccountingGrp/TotalAmt01597
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt42.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt52.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0DR MARC LIPPMAN
IRS990/Form990PartVIISectionAGrp/PersonNm1MERLYN DONATIEN
IRS990/Form990PartVIISectionAGrp/PersonNm2DR STEFFI OESTERREICH
IRS990/Form990PartVIISectionAGrp/PersonNm3BEN PARK
IRS990/Form990PartVIISectionAGrp/PersonNm4C KENT OSBORNE
IRS990/Form990PartVIISectionAGrp/PersonNm5MOTHAFFAR RIMAWI
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5BOARD MEMBER
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02011
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0342250
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt03
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0FL
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0ANNUALLY THIS ORGANIZATION HOSTS THE BREAST CANCER THINK TANK SYMPOSIUM. THE BREAST CANCER THINK TANK SYMPOSIUM DISCUSSES THE NEWEST INFORMATION AND CLINICAL MANAGEMENT OF BREAST CANCER IN ORDER TO IDENTIFY NEW STRATEGIES FOR DIAGNOSIS, PROGNOSIS, TREATMENT AND PREVENTION OF BREAST CANCER IN THE DECADES TO COME. WE STRIVE TO PROVIDE STATE-OF-THE-ART INFORMATION TO ENHANCE THE QUALITY OF EDUCATION, RESEARCH, AND CLINICAL PRACTICE, TO FOSTER PROFESSIONAL GROWTH AND TO STIMULATE ACADEMIC DIALOGUE.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0288261
IRS990/NetAssetsOrFundBalancesEOYAmt0254220
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0288261
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0254220
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ManagementAndGeneralAmt0842
IRS990/OccupancyGrp/TotalAmt0842
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt01346
IRS990/OfficeExpensesGrp/TotalAmt01346
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherExpensesGrp/Desc0SYMPOSIUM VENUE
IRS990/OtherExpensesGrp/Desc1SYMPOSIUM SUPPLIES
IRS990/OtherExpensesGrp/ProgramServicesAmt0347857
IRS990/OtherExpensesGrp/ProgramServicesAmt1262
IRS990/OtherExpensesGrp/TotalAmt0347857
IRS990/OtherExpensesGrp/TotalAmt1262
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0DR MARC LIPPMAN
IRS990/ProfessionalFundraisingInd0false
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0419500
IRS990/PYExcessBenefitTransInd0false
IRS990/PYOtherExpensesAmt0264387
IRS990/PYRevenuesLessExpensesAmt0155113
IRS990/PYTotalExpensesAmt0264387
IRS990/PYTotalRevenueAmt0419500
IRS990/ReconcilationRevenueExpnssAmt0-34041
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0342250
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0419500
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0500810
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt073052
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0109554
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt01445166
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.64340
IRS990ScheduleA/PublicSupportPY170Pct00.73370
IRS990ScheduleA/PublicSupportTotal170Amt0929856
IRS990ScheduleA/SubstantialContributorsTotAmt0515310
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0342250
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0419500
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0500810
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt073052
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0109554
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt01445166
IRS990ScheduleA/TotalSupportAmt01445166
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0ANNUALLY THIS ORGANIZATION HOSTS THE BREAST CANCER THINK TANK SYMPOSIUM. THE BREAST CANCER THINK TANK SYMPOSIUM DISCUSSES THE NEWEST INFORMATION AND CLINICAL MANAGEMENT OF BREAST CANCER IN ORDER TO IDENTIFY NEW STRATEGIES FOR DIAGNOSIS, PROGNOSIS, TREATMENT AND PREVENTION OF BREAST CANCER IN THE DECADES TO COME. WE STRIVE TO PROVIDE STATE-OF-THE-ART INFORMATION TO ENHANCE THE QUALITY OF EDUCATION, RESEARCH, AND CLINICAL PRACTICE, TO FOSTER PROFESSIONAL GROWTH AND TO STIMULATE ACADEMIC DIALOGUE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE BREAST CANCER THINK TANK SYMPOSIUM IS AN ESSENTIAL MEETING THAT WILL CONTRIBUTE SIGNIFICANTLY TO THE ADVANCEMENT OF BREAST CANCER RESEARCH AND CLINICAL CARE. BY FACILITATING CROSS-DISCIPLINARY COLLABORATION AND SHARING THE LATEST KNOWLEDGE, THIS SYMPOSIUM AIMS TO FOSTER THE DEVELOPMENT OF NEW DIAGNOSTIC TOOLS, TREATMENTS, AND PREVENTIVE STRATEGIES THAT WILL SHAPE THE FUTURE OF BREAST CANCER CARE FOR DECADES TO COME. OUR TOP ACHIEVEMENTS ALSO INCLUDE THE FOLLOWING: O ENGAGEMENT: ACTIVE PARTICIPATION FROM A BROAD SPECTRUM OF PROFESSIONALS, INCLUDING CLINICAL AND BASIC RESEARCHERS, INDUSTRY REPRESENTATIVES, AND HEALTHCARE PROVIDERS. O INNOVATIVE INSIGHTS: GENERATION OF NEW IDEAS FOR DIAGNOSTICS, THERAPIES, AND PREVENTION STRATEGIES FOR BREAST CANCER. O COLLABORATION AND PARTNERSHIPS: ESTABLISHMENT OF NEW COLLABORATIONS AMONG RESEARCHERS, CLINICIANS, AND COMPANIES THAT CAN DRIVE FORWARD NEW RESEARCH AND CLINICAL APPLICATIONS. O IMPACT ON FUTURE RESEARCH AND CLINICAL PRACTICE: CONCRETE STEPS TAKEN TOWARD OVERCOMING BARRIERS IN BREAST CANCER CARE, TRANSLATING RESEARCH FINDINGS INTO ACTIONABLE SOLUTIONS FOR THE FUTURE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE BOARD REVIEWS THE FORM 990 BEFORE FILING WITH THE IRS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE BOARD OF DIRECTORS CONDUCTS AN ANNUAL REVIEW OF THE POLICY, AND THE PRESIDENT FORMALLY APPROVES AND SIGNS ALL RELATED RECORDS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST TO THE ORGANIZATION.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0FL
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0288261
IRS990/TotalAssetsEOYAmt0254220
IRS990/TotalAssetsGrp/BOYAmt0288261
IRS990/TotalAssetsGrp/EOYAmt0254220
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt0342250
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt03785
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0372506
IRS990/TotalFunctionalExpensesGrp/TotalAmt0376291
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0288261
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0254220
IRS990/TotalProgramServiceExpensesAmt0372506
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0342250
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0288261
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0254220
IRS990/TravelGrp/ProgramServicesAmt024387
IRS990/TravelGrp/TotalAmt024387
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt04429 HOLLYWOOD BLVD
IRS990/USAddress/AddressLine2Txt0NO 814833
IRS990/USAddress/CityNm0HOLLYWOOD
IRS990/USAddress/StateAbbreviationCd0FL
IRS990/USAddress/ZIPCd033021
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt03
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0DR MARC LIPPMAN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum03052437265
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-07-24
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0BREAST CANCER THINK TANK INC
ReturnHeader/Filer/BusinessNameControlTxt0BREA
ReturnHeader/Filer/EIN0453942883
ReturnHeader/Filer/PhoneNum03052437265
ReturnHeader/Filer/USAddress/AddressLine1Txt04429 HOLLYWOOD BLVD NO 814833
ReturnHeader/Filer/USAddress/CityNm0HOLLYWOOD
ReturnHeader/Filer/USAddress/StateAbbreviationCd0FL
ReturnHeader/Filer/USAddress/ZIPCd033021
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0843085028
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0BRYTEBRIDGE CONSULTING LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt07021 UNIVERSITY BLVD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0WINTER PARK
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0FL
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0327926719
ReturnHeader/PreparerPersonGrp/PhoneNum08778579002
ReturnHeader/PreparerPersonGrp/PreparationDt02025-07-25
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MARIA TAPIA
ReturnHeader/ReturnTs02025-07-25T11:49:57-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.